From: Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey
 | N = 258 |
---|---|
Cannabis type, n (%) | Â |
 Cannabis herb | 163 (79.5) |
 Cannabis resin | 41 (20.0) |
 Cannabis oil | 1 (0.5) |
Route of administration, n (%) (1) | Â |
 Inhalation | 232 (90.6) |
 Oral | 24 (9.4) |
Frequency of consumption, n (%) (3) | Â |
 Experimentation | 1 (0.4) |
 Daily | 130 (55.8) |
 Weekly | 53 (22.8) |
 Monthly | 32 (13.7) |
 Quarterly | 4 (1.7) |
 Annually | 13 (5.6) |
Anteriority of consumption, n (%) (2) | Â |
  ≤ 1 year | 3 (1.2) |
 1 to 3 years | 5 (2.0) |
 3 to 5 years | 29 (11.4) |
 5 to 10 years | 88 (34.6) |
  ≥ 10 years | 129 (50.8) |
Last consumption, n (%) (1) | Â |
  < 48 hours | 201 (78.5) |
  ≤ 1 week | 18 (7.0) |
  ≤ 1 month | 20 (7.8) |
  <  1 year | 17 (6.7) |
Mode of obtaining, n (%) (3) | Â |
 Friends | 116 (47.9) |
 Dealer | 67 (27.7) |
 Purchased without any information | 17 (7.0) |
 Culture | 16 (6.6) |
 Donation | 11 (4.5) |
 Others | 49 (20.2) |
Effect(s) sought, n (%) (2) | Â |
 Calming | 194 (76.1) |
 Euphoria | 56 (22.0) |
 Lettinggo | 17 (6.7) |
 Clairvoyancy | 14 (5.5) |
 Empathogenic | 10 (3.9) |
 Stimulation | 7 (2.7) |
 Getting high | 5 (2.0) |
 Derealization | 4 (1.6) |
 Chemsex | 1 (0.4) |
 Other effects | 21 (8.2) |
Cannabis adverse event(s), n (%) (3) | Â |
 Psychological | 67 (31.3) |
 Somatic | 65 (30.4) |
 Asthenia | 25 (11.7) |
 Badtrip | 9 (4.2) |
 Isolation | 6 (2.8) |
 Cravings | 3 (1.4) |
 Other symptoms | 21 (9.8) |